News

Filter

Current filters:

USAOphthalmics

51 to 60 of 96547 results

Aduro expands deal with Janssen to lung cancer; worth up to $817 million

Aduro expands deal with Janssen to lung cancer; worth up to $817 million

17-10-2014

Privately-held US cancer immunotherapy developer Aduro BioTech has entered into its second agreement…

Aduro BioTechBiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingOncologyResearch

Supply chain pressure can pose serious risk to pharma, experts argue

Supply chain pressure can pose serious risk to pharma, experts argue

16-10-2014

CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, has released the final part of its 2014…

BiotechnologyCPhI WorldwideGlobalPharmaceuticalResearch

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

16-10-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, and Immune Design, a clinical-stage…

FranceImmune DesignPharmaceuticalResearchSanofi PasteurVaccines

Cosmo Pharma plans to move management seat to Ireland

16-10-2014

Recently jilted Italian drugmaker Cosmo Pharmaceuticals says that its board of directors has resolved…

Cosmo PharmaceuticalsIrelandManagementMergers & AcquisitionsPharmaceuticalProductionSalix Pharmaceuticals

Baxter third-qtr earnings hit by costs, but sales rise

16-10-2014

US health care product company Baxter International today reported a 14% drop in net income of $468 million…

Baxter InternationalFinancialPharmaceutical

Russia’s Generium to establish MabThera analogue production

16-10-2014

Generium Group of Companies, one of Russia’s largest producers of innovative drugs, has commissioned…

BiosimilarsBiotechnologyGeneriumMabTheraOncologyProductionRocheRussia

Actavis challenges Quillivant XR patent

16-10-2014

Ireland-headquartered generics major Actavis confirmed that it has filed an Abbreviated New Drug Application…

ActavisGenericsLegalNeurologicalPatentsPfizerQuillivantRegulationTris PharmaUSA

Neuroscience a key feature of AstraZeneca’s collaboration with University of Cambridge

Neuroscience a key feature of AstraZeneca’s collaboration with University of Cambridge

16-10-2014

Anglo-Swedish drug major AstraZeneca, together with its global biologics R&D arm MedImmune, has entered…

AstraZenecaNeurologicalPharmaceuticalResearchUK

FDA FOCUS: The medical marijuana controversy

FDA FOCUS: The medical marijuana controversy

16-10-2014

In the third of a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies…

MarinolPharmaceuticalRegulationUnited StatesUSA

51 to 60 of 96547 results

Back to top